NCT00991198View on ClinicalTrials.gov

The Role of Topically Dissolved Oxygen (TDO) to Ameliorate Signs of Photodamage

PHASE2CompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

January 31, 2010

Study Completion Date

January 31, 2010

Conditions
RosaceaAcne VulgarisAtopic DermatitisSeborrheic Dermatitis
Interventions
DRUG

Topical oxygen

0.5% concentration of Topical oxygen

DRUG

Topical oxygen

0.25% concentration topical oxygen

DRUG

placebo

no O2

Trial Locations (1)

27262

Dermatology Consultants Inc, High Point

Sponsors
All Listed Sponsors
lead

Aria Aesthetics Inc.

INDUSTRY